1[1]Yano Y, Kitagawa N, Gabazza EC. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria. J Clin Endocrinol Metab, 2003, 88(2):736
2[2]De Jong PE, Hillege HL, Pinto-Sietsma SJ,et al. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant ,2003,18:10
3[3]Suzuki K, Kato K, Hanyu O,et al. Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients. Diabetes Res Clin Pract,2001,54(3):173
4[4]Jones CA, Francies ME, Eberhardt MS,et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis,2002,39: 445
5[5]Yusuf S, Sleight P, Pogue J,et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med,2000,342:145
6[6]Bigazzi R,Bianchi S, Baidari D,et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with hypertension predicts. J Hypertens, 1998,16:1325
7[7]Park HY, Schumock GT, Pikard AS,et al. A structruced review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension. Pharmacotherapy,2003, 23(12):1611
8[8]Wathtell K, Palmieri V, Olsen MH,et al. Urine albumin/creatine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertropy: The LIFE study. Losantan intervention for Endpoint Reduction. Am Heart J,2002, 143:319
9[9]Perkins BA, Ficociello LH, Silver KH,et al. Regression of microalbuminuria in type 1 diabetes. N Engl J Med,2003,348:2285
10[10]Tabaei BP, Al-Kassab AS, Ilag LL,et al. Does microalbuminuria predict diabetic nephropathy? Diabetes Care, 2001,24:1560
